WEBVTT - HIV: Racing to Identify a Killer

0:00:06.240 --> 0:00:09.240
<v Speaker 1>HIV was one of the most important viruses of the

0:00:09.240 --> 0:00:13.640
<v Speaker 1>past century. It caused profound suffering, It led to intense

0:00:13.720 --> 0:00:19.320
<v Speaker 1>political and social confrontations and eventually transformations. And for scientists,

0:00:19.880 --> 0:00:23.439
<v Speaker 1>HIV posed a complicated set of problems that still have

0:00:23.560 --> 0:00:27.400
<v Speaker 1>not been entirely solved. On today's show, we're going to

0:00:27.400 --> 0:00:31.320
<v Speaker 1>focus on the scientists and the science. I'm Jacob Goldstein,

0:00:31.400 --> 0:00:34.479
<v Speaker 1>and this is Incubation, a show about viruses. In the

0:00:34.479 --> 0:00:36.800
<v Speaker 1>first half of the show, we'll talk with a virologist.

0:00:37.159 --> 0:00:39.600
<v Speaker 1>She was working at a hospital in the early nineteen

0:00:39.640 --> 0:00:42.239
<v Speaker 1>eighties when the first patients began to show up with

0:00:42.320 --> 0:00:46.040
<v Speaker 1>this deadly disease that no one understood. She was part

0:00:46.040 --> 0:00:49.320
<v Speaker 1>of a team that rushed to identify the virus behind

0:00:49.360 --> 0:00:52.360
<v Speaker 1>the disease. Then, in the second half of the show,

0:00:52.600 --> 0:00:55.560
<v Speaker 1>we'll hear from a physician who's been working for over

0:00:55.680 --> 0:01:02.560
<v Speaker 1>twenty years to develop an HIV vaccine. We're going to

0:01:02.640 --> 0:01:07.479
<v Speaker 1>start today with my conversation with Christine Ruzu. Christine became

0:01:07.560 --> 0:01:10.800
<v Speaker 1>part of a famous team that ultimately wound up in

0:01:10.840 --> 0:01:15.640
<v Speaker 1>an international fight over who discovered HIV in nineteen eighty one.

0:01:15.920 --> 0:01:19.479
<v Speaker 1>Christine was a young researcher in the virology lab at

0:01:19.560 --> 0:01:23.199
<v Speaker 1>Bishaw Claude Bernard Hospital. It's a hospital in Paris that's

0:01:23.240 --> 0:01:28.000
<v Speaker 1>dedicated to infectious diseases. Christine remembers when the first patients

0:01:28.040 --> 0:01:31.160
<v Speaker 1>with this mysterious new illness started coming to the hospital.

0:01:31.600 --> 0:01:36.080
<v Speaker 2>We start to see those patients. They were young, they

0:01:36.120 --> 0:01:41.520
<v Speaker 2>were gay, and they had a lot of infections and

0:01:41.640 --> 0:01:42.560
<v Speaker 2>they were dying.

0:01:43.720 --> 0:01:45.840
<v Speaker 1>Like did you see yourself in them at all? Like

0:01:45.920 --> 0:01:49.280
<v Speaker 1>here of just some young healthy person, suddenly they get

0:01:49.320 --> 0:01:50.280
<v Speaker 1>sick and die.

0:01:50.840 --> 0:01:55.880
<v Speaker 2>Yeah, we had patients with our age. I was thirty

0:01:56.680 --> 0:02:03.920
<v Speaker 2>at the beginning. Those who were hospitalized died rapidly. They

0:02:03.920 --> 0:02:07.720
<v Speaker 2>come to the hospital very late in the disease, and

0:02:08.800 --> 0:02:14.080
<v Speaker 2>within the gay community, I could see progressively some of

0:02:14.120 --> 0:02:17.800
<v Speaker 2>them with big lymphnods, some of them with the caposis

0:02:17.880 --> 0:02:19.800
<v Speaker 2>are comma very difficult.

0:02:20.160 --> 0:02:23.240
<v Speaker 1>And so what are you what are you thinking when

0:02:23.400 --> 0:02:27.799
<v Speaker 1>these when these people start showing up with these strange symptoms.

0:02:28.120 --> 0:02:32.120
<v Speaker 2>From the beginning, the sign of our infection was there.

0:02:33.000 --> 0:02:37.000
<v Speaker 2>When you look at the number in blood of cells,

0:02:37.160 --> 0:02:41.520
<v Speaker 2>you can make the difference between bacteria and virus. Is infection.

0:02:42.360 --> 0:02:48.160
<v Speaker 2>And we we discuss with the different teams and we

0:02:48.240 --> 0:02:52.840
<v Speaker 2>start with the ideas that could be a retrovirus, a

0:02:52.960 --> 0:02:55.160
<v Speaker 2>very specific retrovirus.

0:02:55.680 --> 0:02:58.400
<v Speaker 1>Why do you think retrovirus? We should say, by the way,

0:02:58.440 --> 0:03:01.560
<v Speaker 1>retrovirus is a virus that use is RNA instead of DNA.

0:03:01.600 --> 0:03:02.400
<v Speaker 1>Why do you think it's that?

0:03:03.400 --> 0:03:07.720
<v Speaker 2>So how can I say it was vious.

0:03:07.400 --> 0:03:10.640
<v Speaker 1>Alamodo alamode like it was sort of the fashionable virus.

0:03:10.639 --> 0:03:13.920
<v Speaker 1>It was the it kind of virus, fashionable virus. Yes,

0:03:14.280 --> 0:03:17.560
<v Speaker 1>you and your colleagues have this hypothesis, we think this

0:03:17.600 --> 0:03:19.960
<v Speaker 1>is a retrovirus. What is the first thing you do?

0:03:20.960 --> 0:03:23.600
<v Speaker 2>We went to see Luke Montagnier and Francos virus and

0:03:23.600 --> 0:03:24.560
<v Speaker 2>you see in Pastor in.

0:03:24.520 --> 0:03:29.240
<v Speaker 1>Situew Luke Montaigne worked with Francois Barressing. You see at

0:03:29.240 --> 0:03:32.679
<v Speaker 1>the Pastor Institute, these two scientists who will become very famous.

0:03:32.960 --> 0:03:36.240
<v Speaker 2>Yeah, yeah, And we asked them, do you think that

0:03:36.280 --> 0:03:40.600
<v Speaker 2>it's possible to try to isolate the virus retrovirus? And

0:03:40.640 --> 0:03:46.280
<v Speaker 2>he said, that's a good idea. Maybe we can try. Maybe, Okay,

0:03:46.560 --> 0:03:50.080
<v Speaker 2>we'll do the work. So we come back to the

0:03:50.160 --> 0:03:53.360
<v Speaker 2>working group and we decide to take the lymph nodes

0:03:53.400 --> 0:03:57.000
<v Speaker 2>because they were very big, and to take a blood

0:03:57.600 --> 0:04:00.720
<v Speaker 2>in a nearly a symptomatic patients.

0:04:01.120 --> 0:04:04.800
<v Speaker 1>Okay, So You're at the hospital seeing these patients sick

0:04:05.000 --> 0:04:08.080
<v Speaker 1>with what you think might be a retrovirus, and you're

0:04:08.120 --> 0:04:11.840
<v Speaker 1>taking samples from patients at what seemed like different stages

0:04:11.880 --> 0:04:15.720
<v Speaker 1>of the disease and sending them to these academic researchers

0:04:15.720 --> 0:04:17.080
<v Speaker 1>at the Pastor Institute.

0:04:17.400 --> 0:04:24.839
<v Speaker 2>What happens next fifteen days after Luc Montaignefon and we

0:04:25.000 --> 0:04:29.440
<v Speaker 2>have something. We have something, We have something.

0:04:29.800 --> 0:04:33.480
<v Speaker 1>Front Soise Barre Snusi. That researcher who was working with

0:04:33.520 --> 0:04:37.800
<v Speaker 1>Montagnier had discovered evidence that suggested a retrovirus was in

0:04:37.839 --> 0:04:41.520
<v Speaker 1>fact the culprit for this mysterious disease. The team developed

0:04:41.520 --> 0:04:45.480
<v Speaker 1>a blood test to identify patients with antibodies to this virus.

0:04:46.200 --> 0:04:49.600
<v Speaker 1>Test allowed researchers to diagnose the virus not only in

0:04:49.640 --> 0:04:53.960
<v Speaker 1>gay men, but also in IV drug users and hemophiliacs,

0:04:54.440 --> 0:04:57.680
<v Speaker 1>But the illness was still a mystery, and in particular,

0:04:58.200 --> 0:05:00.880
<v Speaker 1>even though they knew it was a retrovisvirus, no one

0:05:00.880 --> 0:05:05.080
<v Speaker 1>had actually seen and correctly identified it. So now researchers

0:05:05.080 --> 0:05:08.039
<v Speaker 1>around the world are in this race both to help

0:05:08.120 --> 0:05:11.960
<v Speaker 1>patients and to find the virus. On the team, Christine

0:05:12.000 --> 0:05:16.240
<v Speaker 1>was working with an electron microscopist a specialist in looking

0:05:16.279 --> 0:05:20.000
<v Speaker 1>for things through an electron microscope, spent his days trying

0:05:20.040 --> 0:05:21.360
<v Speaker 1>to find this virus.

0:05:22.080 --> 0:05:25.760
<v Speaker 2>He said, for the first days, no, I can't see nothing.

0:05:26.279 --> 0:05:29.599
<v Speaker 2>And then after three days he said, come and see.

0:05:29.680 --> 0:05:31.200
<v Speaker 2>I'm sure there is something.

0:05:31.920 --> 0:05:34.400
<v Speaker 1>What is the microscopycy happening in the cell?

0:05:35.200 --> 0:05:37.680
<v Speaker 2>He sees the budding of the virus at the surface

0:05:37.720 --> 0:05:38.760
<v Speaker 2>of the lymphosize.

0:05:38.960 --> 0:05:42.160
<v Speaker 1>Uh huh, And so does that mean coming out, going in?

0:05:42.240 --> 0:05:43.200
<v Speaker 1>What does budding mean?

0:05:43.360 --> 0:05:48.440
<v Speaker 2>In that kind of budding is when the virus has

0:05:48.480 --> 0:05:52.080
<v Speaker 2>been within the cells he has to get out, and

0:05:52.320 --> 0:05:55.840
<v Speaker 2>he could see free virl particles and he could see

0:05:55.880 --> 0:06:01.120
<v Speaker 2>also that those particles came from those infected cells. Budding

0:06:01.279 --> 0:06:03.960
<v Speaker 2>is a Commondi budding.

0:06:04.160 --> 0:06:07.320
<v Speaker 1>It's sort of exploding out of the cell or leaving the.

0:06:07.279 --> 0:06:10.320
<v Speaker 2>Cell, exactly, the moment of leaving the cell.

0:06:10.440 --> 0:06:12.920
<v Speaker 1>That's so this is like a big moment, right. You're

0:06:12.960 --> 0:06:15.680
<v Speaker 1>not only seeing the virus, but you're actually seeing it

0:06:15.839 --> 0:06:16.560
<v Speaker 1>as it's.

0:06:16.480 --> 0:06:18.520
<v Speaker 2>Leaving the host cell exactly.

0:06:19.320 --> 0:06:21.440
<v Speaker 1>Do you remember when you saw that image for the

0:06:21.480 --> 0:06:22.080
<v Speaker 1>first time.

0:06:22.640 --> 0:06:26.479
<v Speaker 2>Ah, yes, I remember very well, because at that time

0:06:26.960 --> 0:06:31.320
<v Speaker 2>we say, oh, now what we have to do with that.

0:06:32.520 --> 0:06:34.120
<v Speaker 2>We have to organize everything.

0:06:35.080 --> 0:06:37.720
<v Speaker 1>So your response is not Wow, we did it, it's

0:06:37.800 --> 0:06:39.640
<v Speaker 1>oh my god, We've got so much work to do.

0:06:40.000 --> 0:06:44.400
<v Speaker 2>Yeah. You know, in France we say we have the

0:06:44.560 --> 0:06:48.000
<v Speaker 2>nose in the bicycle, I mean.

0:06:49.720 --> 0:06:53.520
<v Speaker 1>The steering the handlebars, just looking at not looking at

0:06:53.760 --> 0:06:56.680
<v Speaker 1>your head down those to the handlebars.

0:06:57.040 --> 0:06:57.840
<v Speaker 2>Yeah, exactly.

0:06:58.080 --> 0:07:01.240
<v Speaker 1>And so that's the moment when you're basic saying we

0:07:01.440 --> 0:07:04.760
<v Speaker 1>found it, we found the virus that is causing this

0:07:04.880 --> 0:07:05.960
<v Speaker 1>mysterious disease.

0:07:06.320 --> 0:07:09.400
<v Speaker 2>Yeah, and a paper with the publish in science.

0:07:10.280 --> 0:07:13.680
<v Speaker 1>Meanwhile, in the United States there is another team working

0:07:13.720 --> 0:07:17.280
<v Speaker 1>to study the disease. It's led by Robert Gallo, a

0:07:17.320 --> 0:07:21.360
<v Speaker 1>famous virologist at the National Institutes of Health. And this

0:07:21.600 --> 0:07:25.320
<v Speaker 1>is where a story of discovery becomes a story of

0:07:25.360 --> 0:07:29.480
<v Speaker 1>a competition, of a fight over who really discovered the virus.

0:07:30.040 --> 0:07:32.680
<v Speaker 1>But it didn't start out as a fight. It started

0:07:32.720 --> 0:07:33.960
<v Speaker 1>out as a collaboration.

0:07:35.280 --> 0:07:38.520
<v Speaker 2>Luke Montagne decided, because he knows very well Bob Gelou

0:07:38.600 --> 0:07:41.800
<v Speaker 2>at that time, he decided to collaborate and to cooperate,

0:07:42.440 --> 0:07:46.679
<v Speaker 2>and he sent samples with the virus to Bob Galu. Okay,

0:07:46.800 --> 0:07:48.040
<v Speaker 2>can you imagine that?

0:07:48.360 --> 0:07:51.520
<v Speaker 1>Well, that's like the ideal of science, right, They're not rivals.

0:07:51.520 --> 0:07:56.360
<v Speaker 1>They're working together to increase humanity's understanding exactly.

0:07:57.080 --> 0:08:04.560
<v Speaker 2>Yeah. Yeah. And then Bob Galou publish a discovery of

0:08:04.760 --> 0:08:05.600
<v Speaker 2>AS virus.

0:08:05.960 --> 0:08:08.960
<v Speaker 1>H huh, you're using air quotes as you say discovery.

0:08:09.040 --> 0:08:15.640
<v Speaker 2>Yeah, yeah, in April nineteen eighty four, and he said,

0:08:16.080 --> 0:08:18.520
<v Speaker 2>we discovers the virus.

0:08:18.600 --> 0:08:21.400
<v Speaker 1>Just from Gallo's point of view, what is his claim

0:08:21.560 --> 0:08:23.680
<v Speaker 1>in eighty four of discovery.

0:08:23.720 --> 0:08:29.760
<v Speaker 2>He claims that the virus was not completely identical to

0:08:30.080 --> 0:08:34.640
<v Speaker 2>our virus, and he says mine is really AS virus

0:08:34.679 --> 0:08:35.560
<v Speaker 2>in the United States.

0:08:35.600 --> 0:08:38.720
<v Speaker 1>So Gallo was saying he discovered the AIDS virus in

0:08:38.760 --> 0:08:42.960
<v Speaker 1>the United States. From your perspective, your lab already discovered

0:08:42.960 --> 0:08:46.200
<v Speaker 1>the virus. What do you think when you read this paper?

0:08:47.800 --> 0:08:50.760
<v Speaker 2>It was a very difficult period of time for us.

0:08:51.160 --> 0:08:54.960
<v Speaker 2>And in France he said, you can't imagine. Of course,

0:08:55.000 --> 0:08:57.600
<v Speaker 2>Bob Gallo is right and your virus is not the

0:08:57.720 --> 0:08:58.160
<v Speaker 2>right one.

0:08:58.559 --> 0:09:01.079
<v Speaker 1>Oh, I would not have guessed that. Wait, even even

0:09:01.120 --> 0:09:03.400
<v Speaker 1>in France they said that. I am surprised.

0:09:03.640 --> 0:09:07.400
<v Speaker 2>Even in France. You know, we were young frenchie. Yeah yeah,

0:09:08.720 --> 0:09:13.719
<v Speaker 2>those little frenchie compared to the bag Gallo, it's not possible.

0:09:14.960 --> 0:09:18.959
<v Speaker 2>Bob Gallo is very important in the nine i H

0:09:19.640 --> 0:09:23.240
<v Speaker 2>compared to us. We are not professor, We were just

0:09:23.400 --> 0:09:26.440
<v Speaker 2>assistant in labs. We are so young.

0:09:27.120 --> 0:09:29.360
<v Speaker 1>What do you think when this is happening and people

0:09:29.440 --> 0:09:31.440
<v Speaker 1>are saying this you personally, we.

0:09:31.800 --> 0:09:37.120
<v Speaker 2>Thought that we had to go more rapidly for the

0:09:37.200 --> 0:09:44.160
<v Speaker 2>demonstration of our RUS and with particularly with zero logical tests.

0:09:44.200 --> 0:09:46.439
<v Speaker 2>I'm in the screening with my test.

0:09:46.880 --> 0:09:48.240
<v Speaker 1>Yeah, you know, we.

0:09:48.040 --> 0:09:52.880
<v Speaker 2>Were working and working and working publishing with US, with Italian,

0:09:53.000 --> 0:09:57.560
<v Speaker 2>with CDC. We have to work more and more to

0:09:57.679 --> 0:10:01.600
<v Speaker 2>show that we were right at that time. So we

0:10:01.840 --> 0:10:07.080
<v Speaker 2>progress a lot with the number of patients which increased.

0:10:07.080 --> 0:10:08.680
<v Speaker 2>That'side time everywhere.

0:10:11.080 --> 0:10:14.600
<v Speaker 1>In nineteen eighty five, the Pastor Institute sued the United

0:10:14.640 --> 0:10:17.920
<v Speaker 1>States government, claiming that Bob Gallo's team had used the

0:10:17.960 --> 0:10:21.520
<v Speaker 1>French samples to isolate the virus and create an HIV

0:10:21.600 --> 0:10:25.480
<v Speaker 1>blood test. The lawsuit was eventually settled, and in April

0:10:25.559 --> 0:10:28.440
<v Speaker 1>nineteen eighty seven, Ronald Reagan, the President of the US,

0:10:28.520 --> 0:10:31.560
<v Speaker 1>and Jacques Chirack, the Prime Minister of France, actually held

0:10:31.640 --> 0:10:35.160
<v Speaker 1>a joint press conference where they announced that both countries

0:10:35.160 --> 0:10:39.080
<v Speaker 1>would share the discovery. That same month, Bob Gallo and

0:10:39.160 --> 0:10:42.839
<v Speaker 1>Luke Montagnier co published a paper explaining the sequence of

0:10:42.880 --> 0:10:45.520
<v Speaker 1>events and sharing credit for discoveries.

0:10:46.480 --> 0:10:53.160
<v Speaker 2>But maybe few years after we had the technology for

0:10:53.880 --> 0:10:58.280
<v Speaker 2>genome sequencing, and you know, the story is the end

0:10:58.320 --> 0:11:02.760
<v Speaker 2>of the story. Genetics sequencing of the virus from Bob

0:11:02.800 --> 0:11:06.600
<v Speaker 2>Gallow's lab and from our LAMB show that the Bob's

0:11:06.640 --> 0:11:10.200
<v Speaker 2>Gatherous lab was exactly the same that our virus.

0:11:12.679 --> 0:11:16.119
<v Speaker 1>After that, genetic sequencing proved that the viruses were identical.

0:11:16.480 --> 0:11:18.760
<v Speaker 1>Bob Gallow's lab said the whole thing was a kind

0:11:18.760 --> 0:11:21.960
<v Speaker 1>of a mix up, the result of an accidental contamination.

0:11:22.920 --> 0:11:25.440
<v Speaker 1>The final verdict in the fight over the discovery of

0:11:25.559 --> 0:11:27.719
<v Speaker 1>HIV came decades later.

0:11:28.240 --> 0:11:32.160
<v Speaker 2>And we waited until two thousand and eight against the

0:11:32.200 --> 0:11:37.000
<v Speaker 2>Nobel price, and Bob Gallo did not receive the Nobel price.

0:11:37.600 --> 0:11:40.520
<v Speaker 2>And the people from the Nobel Price, the jury of

0:11:40.679 --> 0:11:45.160
<v Speaker 2>a Nobel Price, explain us they look for They looked

0:11:45.160 --> 0:11:49.920
<v Speaker 2>at everything in Bob Gatherous lab, everything in Luc Montagni labs,

0:11:49.960 --> 0:11:52.679
<v Speaker 2>and they understood very well as the story with a

0:11:52.679 --> 0:11:57.600
<v Speaker 2>sequencing showing that the virus was our virus.

0:11:58.920 --> 0:12:01.960
<v Speaker 1>Bob Gallo is still all credited with important research on

0:12:02.000 --> 0:12:05.600
<v Speaker 1>the links between HIV and AIDS, and even when the

0:12:05.640 --> 0:12:09.000
<v Speaker 1>Nobel was announced, Luke Montaigner was quoted as saying that

0:12:09.040 --> 0:12:12.160
<v Speaker 1>the Gallo team deserved to share. How did you feel

0:12:12.200 --> 0:12:14.319
<v Speaker 1>when you found out about the Nobel Prize?

0:12:15.800 --> 0:12:21.319
<v Speaker 2>Very well satisfied because you know, we started with history

0:12:21.320 --> 0:12:24.440
<v Speaker 2>in nineteen eighty three and it was a long time

0:12:24.559 --> 0:12:28.720
<v Speaker 2>ago after, yeah, and it was very important to be

0:12:28.920 --> 0:12:30.760
<v Speaker 2>recognized even later.

0:12:31.600 --> 0:12:36.560
<v Speaker 1>Yes, I mean the Nobel Prize is legit recognition. It's

0:12:36.640 --> 0:12:39.640
<v Speaker 1>for real, Like if you want to be vindicated in science,

0:12:39.679 --> 0:12:41.440
<v Speaker 1>it's tough to beat the Nobel Prize.

0:12:41.679 --> 0:12:47.319
<v Speaker 2>Yeah. After yeah, after fighting a lot with US people

0:12:47.559 --> 0:12:52.160
<v Speaker 2>with even in France, it was a Greek moment in Stockholm.

0:12:52.640 --> 0:12:59.240
<v Speaker 2>But we built a working group with the physicians, semanologist

0:12:59.320 --> 0:13:06.520
<v Speaker 2>and self biologists in order to try to understand what

0:13:06.640 --> 0:13:09.640
<v Speaker 2>I want with those patients. And that's a very important

0:13:09.679 --> 0:13:14.320
<v Speaker 2>point of the story because we were a multidisciplinary working

0:13:14.400 --> 0:13:18.800
<v Speaker 2>group and you know it's a listen learned. You can't

0:13:19.120 --> 0:13:23.080
<v Speaker 2>do such a research alone, you can't.

0:13:24.000 --> 0:13:27.120
<v Speaker 1>Wonderful, Thank you so much for your time. It was

0:13:28.000 --> 0:13:28.920
<v Speaker 1>great to talk with you.

0:13:29.240 --> 0:13:30.120
<v Speaker 2>Thank you very much.

0:13:31.640 --> 0:13:35.800
<v Speaker 1>Christine, whoso has spent the last forty years studying HIV

0:13:36.000 --> 0:13:39.600
<v Speaker 1>and AIDS, including work on preventing transmission of the virus

0:13:39.640 --> 0:13:43.480
<v Speaker 1>from mothers to children. She's currently a professor of virology

0:13:43.559 --> 0:13:57.959
<v Speaker 1>at Paris Descartes University. So can we talk about HIV?

0:13:58.640 --> 0:13:59.960
<v Speaker 3>Sure, that would be wonderful.

0:14:01.080 --> 0:14:02.880
<v Speaker 1>My guest for the second half of the show is

0:14:03.000 --> 0:14:06.960
<v Speaker 1>Richard Koup. Richard is the Deputy director of the Vaccine

0:14:07.040 --> 0:14:10.320
<v Speaker 1>Research Center at the National Institutes of Health. He has

0:14:10.360 --> 0:14:14.720
<v Speaker 1>spent his career studying and testing HIV vaccines, and, as

0:14:14.720 --> 0:14:20.040
<v Speaker 1>he explains, creating a vaccine against HIV is this extraordinarily

0:14:20.120 --> 0:14:23.520
<v Speaker 1>hard problem that goes to the heart of why this

0:14:23.760 --> 0:14:28.160
<v Speaker 1>virus is so insidious? Why did you become an infectious

0:14:28.200 --> 0:14:28.880
<v Speaker 1>disease doctor?

0:14:29.600 --> 0:14:33.080
<v Speaker 3>You know, when I was in medical school and my training,

0:14:34.160 --> 0:14:38.320
<v Speaker 3>I noticed that almost all of the different specialties in

0:14:38.400 --> 0:14:42.040
<v Speaker 3>medicine dealt with chronic illness, and infectious disease was the

0:14:42.280 --> 0:14:46.920
<v Speaker 3>one specialty where you didn't have to deal with chronic illnesses.

0:14:46.960 --> 0:14:51.960
<v Speaker 3>What you actually did was you cured people. So people

0:14:52.000 --> 0:14:55.440
<v Speaker 3>would come in with infections, you gave them antibiotics and

0:14:55.480 --> 0:14:58.520
<v Speaker 3>they were cured, and that felt very good.

0:14:59.400 --> 0:15:02.760
<v Speaker 1>Like Christine lose you. Richard Kaup started his career at

0:15:02.760 --> 0:15:06.400
<v Speaker 1>the beginning of the AIDS epidemic, and over time HIV

0:15:06.560 --> 0:15:09.800
<v Speaker 1>would in fact become a chronic disease, but that was

0:15:09.840 --> 0:15:10.440
<v Speaker 1>in the future.

0:15:10.800 --> 0:15:16.360
<v Speaker 3>What we knew then was the genetics of the virus,

0:15:16.360 --> 0:15:20.480
<v Speaker 3>but we didn't really know much about the immune response,

0:15:20.920 --> 0:15:24.040
<v Speaker 3>so we were just sort of mapping out what they

0:15:24.080 --> 0:15:25.160
<v Speaker 3>were responding to.

0:15:25.720 --> 0:15:28.840
<v Speaker 1>It was like we knew what the virus was, but

0:15:28.920 --> 0:15:32.120
<v Speaker 1>we didn't really understand what it did, how it worked.

0:15:32.520 --> 0:15:36.000
<v Speaker 3>Yeah, not really, And we knew that for most viruses,

0:15:36.200 --> 0:15:40.080
<v Speaker 3>in a vaccine, you want to target the envelope protein,

0:15:40.200 --> 0:15:42.800
<v Speaker 3>the protein that's on the surface of the virus that

0:15:42.960 --> 0:15:46.320
<v Speaker 3>is used to enter cells, and so that's what most

0:15:46.360 --> 0:15:48.920
<v Speaker 3>of the first vaccines were directed against.

0:15:49.040 --> 0:15:52.760
<v Speaker 1>Which is like very reasonable, right, Like that's what scientists

0:15:52.960 --> 0:15:55.000
<v Speaker 1>just did with COVID, and it's like that is sort

0:15:55.040 --> 0:15:58.240
<v Speaker 1>of what's floating around in your body and it's what

0:15:58.360 --> 0:16:00.720
<v Speaker 1>the immune system sees. So it seemed it's logical that

0:16:00.720 --> 0:16:05.040
<v Speaker 1>you would want to do that. What happened when when

0:16:05.120 --> 0:16:08.120
<v Speaker 1>you and other researchers tried that with HIV.

0:16:08.720 --> 0:16:12.960
<v Speaker 3>Well, you generated an immune response, so you've got antibodies

0:16:12.960 --> 0:16:15.920
<v Speaker 3>against the envelope protein.

0:16:16.400 --> 0:16:18.680
<v Speaker 1>Seems good, that's what you want, Yeah.

0:16:18.600 --> 0:16:23.720
<v Speaker 3>But those antibodies didn't do anything, they didn't neutralize the virus.

0:16:23.960 --> 0:16:26.720
<v Speaker 1>What was the next thought, What was the next idea?

0:16:27.280 --> 0:16:30.440
<v Speaker 3>The thought then was, well, what we should do is

0:16:30.560 --> 0:16:35.840
<v Speaker 3>stimulate T cells, so T cells recognize virally infected cells

0:16:35.840 --> 0:16:38.800
<v Speaker 3>and kill them. And there were there was a lot

0:16:38.840 --> 0:16:42.040
<v Speaker 3>of data to suggest that people who were long term

0:16:42.120 --> 0:16:45.680
<v Speaker 3>non progressors, so these are people who are infected with

0:16:45.880 --> 0:16:52.120
<v Speaker 3>HIV but they don't progress to full blown AIDS, they

0:16:52.160 --> 0:16:56.000
<v Speaker 3>had really good T cells that were attacking the virus.

0:16:56.760 --> 0:17:01.880
<v Speaker 1>So basically there is this universe of people who have HIV,

0:17:02.000 --> 0:17:06.080
<v Speaker 1>who are HIV positive, but who are not getting really sick.

0:17:06.119 --> 0:17:08.120
<v Speaker 1>And this is an era when most people who get

0:17:08.280 --> 0:17:12.480
<v Speaker 1>HIV get AIDS and die essentially right, get very sick.

0:17:12.520 --> 0:17:15.320
<v Speaker 1>And so you look at these patients and you see

0:17:15.960 --> 0:17:19.000
<v Speaker 1>that there is a particular kind of a cell in

0:17:19.040 --> 0:17:22.000
<v Speaker 1>their immune system that seems to be fighting the disease.

0:17:22.080 --> 0:17:25.680
<v Speaker 3>Is that right, That's absolutely correct. You hit the nail

0:17:25.720 --> 0:17:30.720
<v Speaker 3>on the head there. And so with this insight, people said,

0:17:30.840 --> 0:17:36.080
<v Speaker 3>what we should do is stimulate with a vaccine, not antibodies,

0:17:36.480 --> 0:17:38.720
<v Speaker 3>but CD eight positive T cells.

0:17:39.280 --> 0:17:41.840
<v Speaker 1>So basically, like the first idea was sort of a

0:17:41.880 --> 0:17:45.240
<v Speaker 1>classic vaccine idea like let's create a vaccine based on

0:17:45.240 --> 0:17:48.560
<v Speaker 1>antibodies that didn't work, and so then the second idea

0:17:48.720 --> 0:17:52.240
<v Speaker 1>is to stimulate T cells, this particular part of the

0:17:52.240 --> 0:17:55.200
<v Speaker 1>immune response that vaccines don't usually deal with.

0:17:55.560 --> 0:17:59.400
<v Speaker 3>Instead, it was felt that those vaccines may not keep

0:17:59.440 --> 0:18:04.160
<v Speaker 3>people from getting infected, but if they had the vaccine

0:18:04.320 --> 0:18:07.280
<v Speaker 3>and the people got infected, that they may all become

0:18:07.400 --> 0:18:10.399
<v Speaker 3>long term non progressors, so they wouldn't get sick.

0:18:10.800 --> 0:18:13.240
<v Speaker 1>Which is actually what you care about, right, what you

0:18:13.280 --> 0:18:16.119
<v Speaker 1>want is for people to live long, healthy lives.

0:18:16.520 --> 0:18:17.840
<v Speaker 3>That's absolutely correct.

0:18:18.119 --> 0:18:21.679
<v Speaker 1>So you do this trial and what do you find?

0:18:22.359 --> 0:18:24.760
<v Speaker 3>It did not do what we had hoped it would do.

0:18:25.480 --> 0:18:27.640
<v Speaker 1>And what year more or less is this.

0:18:27.960 --> 0:18:32.320
<v Speaker 3>We've been doing this for twenty years of efficacy trials,

0:18:32.680 --> 0:18:35.760
<v Speaker 3>and seven different trials have been done and none of

0:18:35.800 --> 0:18:38.360
<v Speaker 3>them have shown really good protection.

0:18:39.080 --> 0:18:43.880
<v Speaker 1>So a long time into the history of this disease.

0:18:44.000 --> 0:18:47.639
<v Speaker 1>This is decades of work in and if you'll allow

0:18:47.720 --> 0:18:51.320
<v Speaker 1>me this sort of dumb journaloius question, what was that like?

0:18:52.920 --> 0:18:58.159
<v Speaker 3>It's terribly disappointing. You know, you put a lot of

0:18:58.200 --> 0:19:03.520
<v Speaker 3>effort into this, your hoping that finally something will work

0:19:03.560 --> 0:19:08.240
<v Speaker 3>against this illness. And when it doesn't work at all,

0:19:09.200 --> 0:19:13.160
<v Speaker 3>you're really back to square one. So it's extremely disheartening.

0:19:13.960 --> 0:19:15.960
<v Speaker 1>Why is it so hard to vaccinate against HIV?

0:19:16.520 --> 0:19:22.440
<v Speaker 3>So unlike most viruses, most viruses enter cells of your body,

0:19:22.560 --> 0:19:26.520
<v Speaker 3>they use the machinery of those cells to replicate, and

0:19:26.560 --> 0:19:29.560
<v Speaker 3>then they leave your body and they're gone. They leave,

0:19:30.040 --> 0:19:33.080
<v Speaker 3>and you're no longer sick. When they're not there.

0:19:33.440 --> 0:19:35.680
<v Speaker 1>You get a cold and then you get better.

0:19:35.640 --> 0:19:40.040
<v Speaker 3>Right, and there's no cold virus left in the cells

0:19:40.080 --> 0:19:40.520
<v Speaker 3>of your.

0:19:40.359 --> 0:19:44.840
<v Speaker 1>Body because your immune system destroys all the virus, right.

0:19:45.000 --> 0:19:48.200
<v Speaker 3>And so with a vaccine, all you need to do,

0:19:48.280 --> 0:19:50.800
<v Speaker 3>actually you don't need to prevent the infection. All you

0:19:50.840 --> 0:19:54.120
<v Speaker 3>have to do is knock down the amount of virus

0:19:54.160 --> 0:20:01.080
<v Speaker 3>it's replicating to decrease your symptoms until the virus goes away.

0:20:01.680 --> 0:20:02.080
<v Speaker 1>Okay.

0:20:02.640 --> 0:20:08.960
<v Speaker 3>HIV is different in that it infects certain cells of

0:20:09.000 --> 0:20:13.879
<v Speaker 3>your body and it actually integrates its genome into the

0:20:13.960 --> 0:20:17.520
<v Speaker 3>genome of those cells and it never goes away.

0:20:18.040 --> 0:20:18.840
<v Speaker 1>Huh.

0:20:18.920 --> 0:20:21.200
<v Speaker 3>I like to think of it like playing whack a mole.

0:20:21.800 --> 0:20:25.679
<v Speaker 3>So it's basically hibernating in those cells, and then the

0:20:25.800 --> 0:20:28.159
<v Speaker 3>virus will will pop out every now and then, and

0:20:28.240 --> 0:20:31.280
<v Speaker 3>you need to try and knock it down, and our

0:20:31.480 --> 0:20:37.960
<v Speaker 3>antiretroviral therapy that we give to individuals doesn't do anything

0:20:38.800 --> 0:20:44.840
<v Speaker 3>to the virus that's sitting there hibernating. It's only when

0:20:45.080 --> 0:20:49.240
<v Speaker 3>when it reactivates and pops itself up that the antiretrovirals

0:20:49.320 --> 0:20:50.160
<v Speaker 3>have any effect.

0:20:50.640 --> 0:20:53.600
<v Speaker 1>This is why the antiretrovirals can keep you from getting sick,

0:20:53.640 --> 0:20:55.680
<v Speaker 1>but they cannot cure you per se.

0:20:55.880 --> 0:20:58.520
<v Speaker 3>Yeah, because it it'll never get rid of all of

0:20:58.560 --> 0:21:00.920
<v Speaker 3>those hibernating viruses.

0:21:01.080 --> 0:21:03.880
<v Speaker 1>Uh huh. So what does that mean from the point

0:21:03.880 --> 0:21:05.760
<v Speaker 1>of view of developing a vaccine.

0:21:06.280 --> 0:21:10.359
<v Speaker 3>That means that you have to block every single infection

0:21:10.560 --> 0:21:11.320
<v Speaker 3>from occurring.

0:21:11.640 --> 0:21:16.160
<v Speaker 1>That seems wildly difficult. Tell me, give me some hope.

0:21:16.160 --> 0:21:19.000
<v Speaker 1>Now I am here sitting here thinking there is no way.

0:21:20.520 --> 0:21:22.240
<v Speaker 1>You know, but I don't know anything. Tell me why

0:21:22.240 --> 0:21:22.840
<v Speaker 1>there is a way.

0:21:23.880 --> 0:21:27.719
<v Speaker 3>So certain individuals who are infected with HIV develop what

0:21:27.760 --> 0:21:33.960
<v Speaker 3>we call broadly neutralizing antibodies. So these are antibodies that

0:21:34.359 --> 0:21:41.119
<v Speaker 3>can neutralize seventy eighty ninety ninety five percent of hivs

0:21:41.160 --> 0:21:43.120
<v Speaker 3>that are circulating in the world.

0:21:43.400 --> 0:21:45.840
<v Speaker 1>These are just patients who have HIV who have this

0:21:45.960 --> 0:21:50.120
<v Speaker 1>particularly robust natural immune response absolutely.

0:21:50.400 --> 0:21:54.000
<v Speaker 3>So we know two things. One that there is a

0:21:54.000 --> 0:21:57.920
<v Speaker 3>way that the immune system can develop these types of antibodies.

0:21:58.720 --> 0:22:02.120
<v Speaker 3>The other thing that we know is that these antibodies

0:22:02.200 --> 0:22:08.800
<v Speaker 3>target multiple different sites on the HIV envelope protein. So

0:22:08.840 --> 0:22:12.960
<v Speaker 3>there are multiple targets on the HIV envelope that can

0:22:13.000 --> 0:22:16.680
<v Speaker 3>be used in the vaccine to stimulate these types of antibodies.

0:22:17.400 --> 0:22:20.920
<v Speaker 3>And we have actually done a clinical trial called the

0:22:20.960 --> 0:22:24.280
<v Speaker 3>AMP trial, where we took one of these broadly neutralizing

0:22:24.280 --> 0:22:27.000
<v Speaker 3>antibodies and we gave it to people who were at

0:22:27.080 --> 0:22:32.040
<v Speaker 3>risk of HIV infection, and at a certain level, those

0:22:32.200 --> 0:22:34.960
<v Speaker 3>individuals were protected against infection.

0:22:35.800 --> 0:22:39.800
<v Speaker 1>And as I understand it, that technique works to protect

0:22:39.800 --> 0:22:43.840
<v Speaker 1>people against some strains of HIV, but not all, right,

0:22:44.080 --> 0:22:48.000
<v Speaker 1>And so what percentage of strains were people protected against

0:22:48.040 --> 0:22:49.000
<v Speaker 1>in that trial.

0:22:49.000 --> 0:22:53.000
<v Speaker 3>For this antibody, It was it was about thirty percent

0:22:53.080 --> 0:22:53.879
<v Speaker 3>of viruses.

0:22:54.119 --> 0:22:58.880
<v Speaker 1>Okay, so that not that broadly neutralizing in that instance.

0:22:59.240 --> 0:23:02.640
<v Speaker 3>No, but this was one of the very first broadly

0:23:02.680 --> 0:23:06.000
<v Speaker 3>neutralizing antibodies that we had that we did this trial with.

0:23:06.119 --> 0:23:11.959
<v Speaker 3>There are much broader and better neutralizing antibodies that are

0:23:11.960 --> 0:23:15.520
<v Speaker 3>available now. But what this is also showing us is

0:23:15.600 --> 0:23:19.760
<v Speaker 3>the roadmap of if we can develop a vaccine that

0:23:19.880 --> 0:23:25.760
<v Speaker 3>will recapitulate the development of these broadly neutralizing antibodies in

0:23:25.880 --> 0:23:30.520
<v Speaker 3>people through immunization rather than through infection. If we can

0:23:30.600 --> 0:23:35.080
<v Speaker 3>get that level of antibody high enough, then we know

0:23:35.200 --> 0:23:36.680
<v Speaker 3>that they should be protected.

0:23:38.880 --> 0:23:41.840
<v Speaker 1>So the basic idea is, like, we have these antibodies

0:23:41.840 --> 0:23:44.560
<v Speaker 1>that seem to work, let's develop a vaccine that can

0:23:44.680 --> 0:23:46.480
<v Speaker 1>induce people to develop these antibodies.

0:23:47.040 --> 0:23:51.880
<v Speaker 3>Yes, that's exactly it. So there's still many big hurdles

0:23:51.880 --> 0:23:54.800
<v Speaker 3>to get over, but the initial studies have shown that

0:23:54.840 --> 0:24:00.560
<v Speaker 3>we can actually get the immune cells in the body

0:24:00.600 --> 0:24:03.960
<v Speaker 3>to start producing the correct type of antibodies.

0:24:04.320 --> 0:24:07.160
<v Speaker 1>These broadly neutralizing antibodies that we want.

0:24:07.080 --> 0:24:11.840
<v Speaker 3>Well, they're sort of the precursors of the broadly neutralizing anivites.

0:24:11.920 --> 0:24:14.800
<v Speaker 1>They're on the JV team. With some work, they can

0:24:14.920 --> 0:24:15.800
<v Speaker 1>make the varsity.

0:24:16.160 --> 0:24:20.720
<v Speaker 3>We need to shepherd them along, mentor them, tutor them,

0:24:20.760 --> 0:24:23.000
<v Speaker 3>and get them to be broadly neutralizing.

0:24:23.359 --> 0:24:26.640
<v Speaker 1>So still a long way away. Clearly, it's a profoundly

0:24:26.680 --> 0:24:31.679
<v Speaker 1>difficult virus to vaccinate against. Drug treatment for HIV, on

0:24:31.760 --> 0:24:35.920
<v Speaker 1>the other hand, has been quite successful, right, and now

0:24:35.960 --> 0:24:42.240
<v Speaker 1>you can do prophylaxis with drugs, which is great. Obviously,

0:24:42.359 --> 0:24:45.800
<v Speaker 1>it reduces human suffering a tremendous amount. Do we need

0:24:45.880 --> 0:24:48.359
<v Speaker 1>vaccines less because the drugs work so well.

0:24:49.240 --> 0:24:53.399
<v Speaker 3>It gives us a bit of a breather in that

0:24:53.440 --> 0:24:57.240
<v Speaker 3>we know that there are other ways to protect people

0:24:57.280 --> 0:25:01.359
<v Speaker 3>who are at risk of HIV infection. But there's a

0:25:01.520 --> 0:25:07.080
<v Speaker 3>lot of healthcare delivery that would need to go into

0:25:07.160 --> 0:25:12.000
<v Speaker 3>protecting the world against HIV in the absence of a vaccine,

0:25:12.400 --> 0:25:15.359
<v Speaker 3>and you need the infrastructure to do that, And in

0:25:15.400 --> 0:25:17.439
<v Speaker 3>parts of the world it's hard to get to the

0:25:17.520 --> 0:25:23.560
<v Speaker 3>people to actually give the medications that frequently. A vaccine

0:25:23.600 --> 0:25:27.160
<v Speaker 3>just makes it much easier to provide that protection.

0:25:27.840 --> 0:25:30.200
<v Speaker 1>And it seems like there is at least some correlation

0:25:30.400 --> 0:25:33.399
<v Speaker 1>between parts of the world where it's hard to get

0:25:33.520 --> 0:25:36.560
<v Speaker 1>people HIV drugs all the time and places where kind

0:25:36.560 --> 0:25:40.680
<v Speaker 1>of suffering from HIV is high.

0:25:40.720 --> 0:25:41.400
<v Speaker 3>Absolutely.

0:25:41.920 --> 0:25:49.080
<v Speaker 1>It's interesting how science generally is more often than not

0:25:49.200 --> 0:25:54.159
<v Speaker 1>the story of things not working. Right. We tend, you know,

0:25:54.600 --> 0:25:57.679
<v Speaker 1>in the media, say to focus on things that work,

0:25:58.440 --> 0:26:01.280
<v Speaker 1>but I feel like in the aggregate, science is things

0:26:01.320 --> 0:26:04.600
<v Speaker 1>not working. And I'm curious, you have spent a lot

0:26:04.600 --> 0:26:06.879
<v Speaker 1>of time working on things not working. Sort of what

0:26:07.000 --> 0:26:10.040
<v Speaker 1>have you learned from working on such a hard project.

0:26:10.760 --> 0:26:16.200
<v Speaker 3>The most difficult problems are the most interesting to work on.

0:26:17.119 --> 0:26:21.240
<v Speaker 3>For all the work we've done on HIV vaccines, we

0:26:21.280 --> 0:26:25.600
<v Speaker 3>don't have anything that's really working yet, but we learned

0:26:26.160 --> 0:26:30.639
<v Speaker 3>so much that actually helped with the development of the

0:26:30.960 --> 0:26:35.480
<v Speaker 3>RSV vaccine, with the development of the COVID vaccine, and

0:26:35.560 --> 0:26:39.560
<v Speaker 3>so we see these other successes that have come out

0:26:39.560 --> 0:26:43.199
<v Speaker 3>of our hard work on HIV, and so that really

0:26:43.400 --> 0:26:47.040
<v Speaker 3>helps us to say, well, we may not have gotten

0:26:47.080 --> 0:26:51.919
<v Speaker 3>there for HIV yet, but we've helped in other ways

0:26:52.400 --> 0:26:55.080
<v Speaker 3>and for other diseases are Do you.

0:26:55.119 --> 0:26:57.399
<v Speaker 1>Feel like you're generally an optimistic person.

0:26:58.600 --> 0:27:00.959
<v Speaker 3>I hope so. I don't think I I'm as optimistic

0:27:00.960 --> 0:27:04.040
<v Speaker 3>as some people I know, But you know I'm not

0:27:04.119 --> 0:27:05.000
<v Speaker 3>a Debbie downer.

0:27:05.240 --> 0:27:06.720
<v Speaker 1>Yes, you know.

0:27:06.800 --> 0:27:10.800
<v Speaker 3>I think if I were on my own trying to

0:27:10.880 --> 0:27:13.840
<v Speaker 3>do this, it wouldn't work. But the community of the

0:27:14.320 --> 0:27:21.240
<v Speaker 3>HIV vaccine researchers sort of keep each other optimistic and

0:27:21.320 --> 0:27:22.120
<v Speaker 3>moving forward.

0:27:24.200 --> 0:27:26.720
<v Speaker 1>Thanks very much for your time. I really appreciate it.

0:27:26.720 --> 0:27:27.840
<v Speaker 3>It was my pleasure.

0:27:27.960 --> 0:27:36.960
<v Speaker 1>Thank you very much. Richard Taut has been researching HIV

0:27:37.119 --> 0:27:40.359
<v Speaker 1>for thirty five years and working on vaccines for twenty

0:27:40.359 --> 0:27:43.720
<v Speaker 1>five He's the Deputy director at the Vaccine Research Center

0:27:43.840 --> 0:27:47.400
<v Speaker 1>at the National Institutes of Allergy and Infectious Disease at

0:27:47.440 --> 0:27:51.359
<v Speaker 1>Anahe thanks to both my guests, Christine Rouziu and Richard

0:27:51.440 --> 0:27:58.439
<v Speaker 1>Kaup next week. There's lots of mosquitoes in the world,

0:27:58.800 --> 0:28:01.080
<v Speaker 1>and not all of them are welly good at spreading disease,

0:28:01.160 --> 0:28:05.040
<v Speaker 1>butadies Agypty is one of the best mosquitoes viruses and

0:28:05.080 --> 0:28:13.679
<v Speaker 1>the history of the world. Incubation is a co production

0:28:13.760 --> 0:28:17.920
<v Speaker 1>of Pushkin Industries and Ruby Studio at iHeartMedia. It's produced

0:28:17.920 --> 0:28:21.080
<v Speaker 1>by Kate Ferby and Brittany Cronin. The show is edited

0:28:21.080 --> 0:28:24.960
<v Speaker 1>by Lacey Roberts. It's mastered by Sarah Brigueire, fact checking

0:28:25.080 --> 0:28:28.800
<v Speaker 1>by Joseph Friedman. Our executive producers are Lacey Roberts and

0:28:28.800 --> 0:28:31.920
<v Speaker 1>Matt Romano. I'm Jacob Goldstein. Thanks for listening.